Author: digi

SOP for Conducting Stability Studies for Drug Products in Compliance with Indian Regulatory Requirements (CDSCO)

SOP for Conducting Stability Studies for Drug Products in Compliance with Indian Regulatory Requirements (CDSCO) Guidelines for Stability Testing of Drug Products as per Indian Regulatory Requirements (CDSCO) 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability studies for drug products in accordance with the Central Drugs…

Stability Studies SOP

Audit Findings Related to Incorrect Expiry Claims

Incorrect expiry claims are a major source of regulatory non-compliance in pharmaceutical inspections. Whether due to mislabeling, unsupported shelf life extensions, or stability data mismatches, such findings often result in warning letters, product recalls, or even import alerts. This tutorial explains the audit findings most frequently cited by agencies like the USFDA, EMA, and CDSCO,…

Shelf Life and Expiry, Shelf Life vs. Expiration Date: Key Differences

Linking Protocol Design to Label Claim Shelf Life

Designing a stability study protocol isn’t just a procedural task—it directly influences the shelf life printed on the product’s label. Regulatory agencies such as the USFDA, EMA, and CDSCO expect a clear link between protocol structure and the justification for the expiry date. Without a robust design, your product may be assigned a shorter-than-necessary shelf…

Protocols and Reports, Stability Study Protocols for Different Drug Types

How to Audit-Proof Your Stability Data Documentation

Stability data is a cornerstone of pharmaceutical product quality and shelf-life assurance. But when regulatory agencies like the EMA or USFDA come knocking, your documentation must do more than exist — it must pass intense scrutiny. “Audit-proofing” your stability data means building documentation systems that are complete, consistent, and compliant with ALCOA+ and GMP principles….

Regulatory Guidelines, Significant Changes and Data Integrity Compliance

Monitor API Physical Form in Stability to Detect Polymorph and Amorphous Shifts

Understanding the Tip: Why monitoring API solid state is essential: APIs may exist in multiple physical forms such as crystalline polymorphs, solvates, hydrates, or amorphous states—each with unique solubility, bioavailability, and stability characteristics. During storage, environmental stress like heat and humidity can trigger transitions from one form to another, affecting dissolution rate, absorption, and even…

Stability Study Tips

QbD vs Traditional Stability Study Planning: A Comparative Approach

Stability studies are a cornerstone of pharmaceutical product development, determining shelf life, storage conditions, and regulatory acceptance. Two planning paradigms exist: the legacy, rule-based traditional approach and the modern, science-driven Quality by Design (QbD) methodology. Understanding their differences is vital for pharma professionals aiming to enhance efficiency, ensure compliance, and support faster approvals. 📜 Traditional…

Pharmaceutical Quality and Practices, Quality by Design (QbD) in Stability Testing

Protocol Harmonization Across Global Stability Programs

In an increasingly globalized pharmaceutical industry, harmonizing stability protocols across different markets is no longer a luxury—it’s a regulatory necessity. Global drug submissions require stability data that meets the expectations of ICH as well as region-specific health authorities such as USFDA, EMA, and CDSCO. Misalignment between protocols can lead to inconsistent data, regulatory questions, and…

Protocols and Reports, Stability Study Protocols for Different Drug Types

Common Regulatory Observations Related to Data Integrity During Change Implementation

Regulatory authorities such as USFDA, EMA, and CDSCO have intensified their focus on data integrity, especially during the implementation of significant changes in pharmaceutical manufacturing. Whether the change involves equipment upgrades, method validation, or protocol updates during stability studies, poor data handling can trigger severe non-compliance findings. In this regulatory-focused article, we explore common observations…

Regulatory Guidelines, Significant Changes and Data Integrity Compliance

Developing SOPs for Shelf Life Extension Procedures

Extending the shelf life of pharmaceutical products is a regulatory-sensitive process that must be supported by robust data and documented through standard operating procedures (SOPs). Shelf life extension SOPs serve as internal controls to guide teams through the re-evaluation of expiry dates based on stability data, ensuring GMP compliance, patient safety, and regulatory acceptability. This…

Shelf Life and Expiry, Shelf Life vs. Expiration Date: Key Differences

Using Prior Knowledge in QbD-Driven Stability Planning

In pharmaceutical development, the Quality by Design (QbD) approach emphasizes scientific understanding and proactive quality planning. One of its most powerful but often underutilized tools is the use of prior knowledge—data and insights gathered from previous development projects, products, or platforms. When integrated into stability planning, this information can drastically reduce unnecessary testing, streamline timelines,…

Pharmaceutical Quality and Practices, Quality by Design (QbD) in Stability Testing